Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
2d
GlobalData on MSNGLP-1RAs and opioid use disorder: a new frontier in addiction treatmentGlucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...
The truth is that muscle growth can vary widely from one person to another. Here's how to maximize yours. Ever wonder why ...
Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
4d
News Medical on MSNDiabetes drugs may boost brain health but experts warn of risksRAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.
Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results